|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
11.06(B) |
Last
Volume: |
666,758 |
Avg
Vol: |
474,971 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
5 |
Total Shares Sold |
1,636 |
25,558 |
49,996 |
92,833 |
Total Sell Value |
$374,194 |
$6,377,856 |
$11,292,577 |
$21,658,880 |
Total People Sold |
2 |
6 |
6 |
8 |
Total Sell Transactions |
2 |
10 |
16 |
28 |
End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Foster James C |
Chairman, President and CEO |
|
2020-02-23 |
4 |
D |
$173.64 |
$346,238 |
D/D |
(1,994) |
291,256 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2020-02-23 |
4 |
D |
$173.64 |
$65,636 |
D/D |
(378) |
21,256 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2020-02-23 |
4 |
D |
$173.64 |
$54,697 |
D/D |
(315) |
18,329 |
|
- |
|
Girshick Birgit |
Corporate Executive VP |
|
2020-02-23 |
4 |
D |
$173.64 |
$54,697 |
D/D |
(315) |
23,091 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2020-02-23 |
4 |
D |
$173.64 |
$54,697 |
D/D |
(315) |
19,680 |
|
- |
|
Johst David P |
Corporate Executive VP |
|
2020-02-23 |
4 |
D |
$173.64 |
$149,678 |
D/D |
(862) |
225,358 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2020-02-23 |
4 |
D |
$173.64 |
$9,724 |
D/D |
(56) |
1,992 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2020-02-22 |
4 |
D |
$173.64 |
$314,983 |
D/D |
(1,814) |
293,250 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2020-02-22 |
4 |
D |
$173.64 |
$59,732 |
D/D |
(344) |
21,634 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2020-02-22 |
4 |
D |
$173.64 |
$49,835 |
D/D |
(287) |
18,644 |
|
- |
|
Girshick Birgit |
Corporate Executive VP |
|
2020-02-22 |
4 |
D |
$173.64 |
$53,481 |
D/D |
(308) |
23,406 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2020-02-22 |
4 |
D |
$173.64 |
$55,044 |
D/D |
(317) |
19,995 |
|
- |
|
Johst David P |
Corporate Executive VP |
|
2020-02-22 |
4 |
D |
$173.64 |
$133,703 |
D/D |
(770) |
226,220 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2020-02-22 |
4 |
D |
$173.64 |
$8,856 |
D/D |
(51) |
2,048 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2020-02-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
295,064 |
|
- |
|
Milne George M Jr |
Director |
|
2020-02-18 |
4 |
S |
$176.07 |
$1,262,430 |
D/D |
(7,170) |
27,037 |
|
3% |
|
Milne George M Jr |
Director |
|
2020-02-18 |
4 |
OE |
$43.39 |
$395,572 |
D/D |
7,170 |
34,207 |
|
- |
|
Wallman Richard F |
Director |
|
2020-02-14 |
4 |
S |
$174.29 |
$615,258 |
D/D |
(3,530) |
29,367 |
|
-1% |
|
Wallman Richard F |
Director |
|
2020-02-14 |
4 |
OE |
$52.29 |
$184,584 |
D/D |
3,530 |
32,897 |
|
- |
|
Wallman Richard F |
Director |
|
2020-02-13 |
4 |
S |
$172.02 |
$1,233,391 |
D/D |
(7,170) |
29,367 |
|
0% |
|
Wallman Richard F |
Director |
|
2020-02-13 |
4 |
OE |
$43.39 |
$395,572 |
D/D |
7,170 |
36,537 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2020-02-13 |
4 |
S |
$171.88 |
$2,578,440 |
D/D |
(15,000) |
298,064 |
|
0% |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2020-02-13 |
4 |
S |
$172.11 |
$1,187,699 |
D/D |
(6,901) |
18,931 |
|
0% |
|
Bertolini Robert J |
Director |
|
2020-02-13 |
4 |
S |
$170.41 |
$1,221,819 |
D/D |
(7,170) |
27,875 |
|
0% |
|
Bertolini Robert J |
Director |
|
2020-02-13 |
4 |
OE |
$43.39 |
$395,572 |
D/D |
7,170 |
35,045 |
|
- |
|
1200 Records found
|
|
Page 21 of 48 |
|
|